- About
- PsychU For You
- Topics
- Events
- Content
The Unicorns Of Behavioral Health: Who They Are & How They Impact Patient Care
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
The Unicorns Of Behavioral Health: Who They Are & How They Impact Patient Care
By July 2021, investments in digital health exceeded all of 2020. Just in the U.S. $29.1 billion was funneled into digital health startups. Among the top funded digital health clinical domains mental health took the lead at $5.1 billion on its own. This is over 10 times the amount it was at in 2017 and $3.3 billion more than any other clinical indication.1
It has been almost 10 years since Aileen Lee coined the term “unicorn” — a privately held company valued over $1 billion.2 In behavioral health, companies that have achieved unicorn status include now commonly known names such Talkspace, Calm, and Lyra Health. These companies with their investment dollars are already reshaping patient care and care delivery.3
Join Otsuka and OPEN MINDS as we explore how patient care is evolving in the face of the behavioral health unicorns. What it means strategically for your organization and how patient care is impacted.
In this webinar attendees will:
- Learn what changed expectations patients carry when it comes to behavioral health care delivery and quality
- Gain insight on how to help your organization be adaptable and form partnerships when “business as usual” will not stand up to muster anymore
- See how the value equation has changed for things like remote care coordination, remote primary care professionals, clinical decision support at the point of care, and much more
References
- Oss, M. E. (2022, January 27). The bet is on Digital. OPEN MINDS. Retrieved August 13, 2022, from https://openminds.com/market-intelligence/executive-briefings/the-bet-is-on-digital/
- Oss, M. E. (2022, January 21). The unicorn next door. OPEN MINDS. Retrieved August 13, 2022, from https://openminds.com/market-intelligence/executive-briefings/the-unicorn-next-door/
- Oss, M. E. (2021, March 5). How 34 health care unicorns are changing your world;. OPEN MINDS. Retrieved August 13, 2022, from https://openminds.com/market-intelligence/executive-briefings/how-34-health-care-unicorns-are-changing-your-world/
Monica E. Oss
Chief Executive Officer and Founder of OPEN MINDS
MoreMonica E. Oss, M.S., Chief Executive Officer and Senior Associate, is the founder of OPEN MINDS. For the past three decades, Ms. Oss has led the OPEN MINDS team and its research on health and human service market trends and its national consulting practice. Ms. Oss is well known for her numerous books and articles focused on the strategic and marketing implications of the evolving health and human service field. She has unique expertise in payer financing models, provider rate setting, and service pricing. She has led numerous engagements with state Medicaid plans, county governments, private insurers, managed care programs, service provider organizations, technology vendors, neurotechnology and pharmaceutical organizations, and investment banking firms – with a focus on the implications of financing changes on delivery system design.
Paul M. Duck
Senior Associate, OPEN MINDS & Former Vice President of Strategy & Development, Beacon Health Options
MoreMr. Duck currently serves as a Senior Associate at OPEN MINDS and brings over 30 years of experience in leadership and management focusing on managed care, health information technology, and strategy and business development. Before joining the OPEN MINDS team, Mr. Duck was the Vice President of Strategy & Development for Beacon Health Options, the Vice President of Business Development for Netsmart Technologies, and Chief Executive Officer for Coastal Orthopedics. Mr. Duck earned his Bachelor of Arts in Business Management from Case Western Reserve University and an Associate of Arts in Electronic Engineering Technology from the Electronic Technology Institute.
Arden Arslanyan, PharmD (OPDC)
Managed Market Liaison
MoreArden Arslanyan, PharmD, is a Managed Market Liasion with Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Arden has held various clinical roles within Express Scripts supporting Medicare, Commercial, and Workers’ Comp lines of business. He attended Nova Southeastern University and completed a post-doctoral fellowship program in medical information in conjunction with Rutgers and Janssen Scientific Affairs.Ms. Oss and Mr. Duck are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr. Arslanyan is an employee of OPDC.
Related Events
Registration
- PsychU For You
